InsidersTradesSigma
Track the Veraxa Biotech AG - Post de-SPAC stock price and the full insider trade history of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the supervision of SEC (Form 4). The latest transaction was disclosed on 31 August 2026 (Acquisition). Among the most active insiders: Antz Christoph Rudiger. All data is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
Veraxa Biotech AG is a biotechnology company that has recently completed a merger with a special purpose acquisition company. It is listed on NASDAQ under the ticker XNAS.